A breakthrough by a Melbourne-based medical institute is set to drastically improve treatment for ovarian cancer and will enable women to retain their fertility through the diagnosis phase.
Ovarian Cancer Australia Advocacy and Support Program Chief Sue Hegarty said the new test developed will improve diagnosis for women and reduce unnecessary surgery.
“We do know that it is Australia's deadliest female cancer, that it’s been very stubborn to treat, the five-year survival rate just being 49 per cent, we know we need to have more research and a test like this is a really promising sign for the treatment of the disease in the future,” she told Sky News Australia.
